23andMe Holding Co.·4

Feb 22, 5:12 PM ET

Hillan Kenneth J. 4

4 · 23andMe Holding Co. · Filed Feb 22, 2023

Insider Transaction Report

Form 4
Period: 2023-02-20
Hillan Kenneth
Head of Therapeutics
Transactions
  • Tax Payment

    Class A Common Stock

    2023-02-20$2.87/sh5,457$15,662191,705 total
Footnotes (1)
  • [F1]The closing price on February 17, 2023, the fair market used for the transaction date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION